These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 32070484)
1. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma. Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484 [TBL] [Abstract][Full Text] [Related]
2. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma. Zhang X; Li W; Li S; Zhang Z; Song W Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion. Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857 [TBL] [Abstract][Full Text] [Related]
4. LncRNA TSPEAR-AS1 predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma and promotes metastasis via miR-1915-5p. Zhang Y; Wang F; Wang Y Virus Res; 2022 Jul; 315():198788. PubMed ID: 35477008 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898 [TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy. Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529 [TBL] [Abstract][Full Text] [Related]
7. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801 [TBL] [Abstract][Full Text] [Related]
8. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells. Zhong Y; Li Y; Song T; Zhang D Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53. Luo X; Zhou N; Wang L; Zeng Q; Tang H Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924 [TBL] [Abstract][Full Text] [Related]
11. Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma. Zhang L; He T; Yan Y; Zhang Y; Zhou X; Huang P; Kong Y; Xie M; Zhang L; Sun Q; Zhou D; Xie H; Zhou L; Zheng S; Wang W Biomed Res Int; 2016; 2016():3608914. PubMed ID: 27896271 [TBL] [Abstract][Full Text] [Related]
12. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation. Su Y; Xie R; Xu Q Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102025. PubMed ID: 36170961 [TBL] [Abstract][Full Text] [Related]
13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
14. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128 [TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
16. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development. Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835 [TBL] [Abstract][Full Text] [Related]
17. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression. Jing GY; Zheng XZ; Ji XX J Clin Lab Anal; 2021 Apr; 35(4):e23717. PubMed ID: 33566427 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks. Zhao X; Bai Z; Li C; Sheng C; Li H Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578 [TBL] [Abstract][Full Text] [Related]
19. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p. Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161 [TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]